A combined gene delivery by co-transduction of adenoviral and retroviral vectors for cancer gene therapy

Cancer Letters

Volumn 184, Issue 2, 2002, Pages 179-188

  Pan, Yujun ^a   Zhai, Peng ^a   Dashti, Azar M ^a   Wu, Shili ^a   Lin, Xinli ^a   Wu, Min ^b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adenoviral vector; Cancer gene therapy; Gene delivery; Retroviral vector

Indexed keywords

ADENOVIRUS VECTOR; GANCICLOVIR; RETROVIRUS VECTOR; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; INTERMETHOD COMPARISON; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CELL DIVISION; FEMALE; GENE THERAPY; GENES, GAG; GENES, POL; GENETIC MARKERS; HUMANS; KINETICS; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; RETROVIRIDAE; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

SIMPLEXVIRUS;

EID: 0037190799     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00241-0     Document Type: Article

References (28)

1. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
2. Gene therapy restores vision in a canine model of childhood blindness
3. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
4. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
5. Construction of new retroviral producer cells from adenoviral and retroviral vectors
6. Chimeric viral vectors - The best of both worlds?
7. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector
8. Frequency and stability of chromosomal integration of adenovirus vectors
9. Progress in the use of gene transfer methods to treat genetic blood diseases
10. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells
11. Tansgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses
12. Retroviruses as vectors
13. Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase
14. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors
15. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines
16. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit
17. Site-specific gene expression in vivo by direct gene transfer into the arterial wall
18. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
19. Internal initiation of translation in retroviral vectors carrying picornavirus 5 non-translated regions
20. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
21. An efficient and flexible system for construction of adenovirus vectors with insertions or deletion in early regions 1 and 3
22. Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus
23. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivitor with nuclear localization signal
24. VSV-G-pseudotyped retroviral packaging through adenivirus-mediated inducible gene expression
25. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome
26. Adenoviral/retroviral vector chimeras: A novel strategy to achieve high-efficiency stable transduction in vivo
27. Adeno-retroviral chimeric viruses as in vivo transducing agents
28. Adenoviral/retroviral combination vectors incorporating the high titers and infectivity of adenoviral vectors with the integration functions of retroviral vectors